Loading clinical trials...
Loading clinical trials...
The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions based on activation maps obtained with different thresholds in patients with benign and biopsy proven low-grade brain neoplasms. Another objective is to access the impairment in neurological function in image guided intracranial radiotherapy using neurocognitive assessment tools and to derive dose response curves relating the impairment in a particular neurological function to the FED received by the area of eloquent brain corresponding to it.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Start Date
June 1, 2004
Primary Completion Date
January 1, 2011
Completion Date
January 1, 2011
Last Updated
February 24, 2012
44
ACTUAL participants
Lead Sponsor
University of Wisconsin, Madison
Collaborators
NCT05839379
NCT05099003
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06860594